Search results :

Atomoxetine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: N06BA09

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Dry mouth Dry mouth 1% - 21% 1% - 7% x x x x x x x x x x x x x x x
Abdominal pain upper Abdominal pain upper very common, 16% - 20% 9% - 16% x x x x x x x x x x
Headache Headache very common, 3% - 27% 1% - 25% x x x x x x x x x x x x x x x
Abdominal pain Abdominal pain very common, 7% - 18% 4% - 13% x x x x x x x x x
Gastrointestinal pain Abdominal pain very common, 7% - 18% 4% - 13% x x x x x x x x x
Middle insomnia Middle insomnia common, 4% - 16% 1% - 8% x x x x x x x x x x x x
Tachycardia Tachycardia very common x x x x x x x x x x
Abdominal discomfort Abdominal discomfort very common x x x x
Upset stomach very common x x x x
Blood pressure increased Blood pressure increased postmarketing, very common x x x x x x x x x x
Epigastric discomfort Epigastric discomfort very common x x x x
Insomnia Insomnia common, 13% - 16% 6% - 8% x x x x x x x x x x x x x x x
Decreased appetite Decreased appetite 10% - 16% 2% - 6% x x x x x x x x x x x x x x x
Anorexia common, 3% 1% x x x x x x x x x x x x x x x
Nausea Nausea very common, 7% - 26% 2% - 8% x x x x x x x x x x x x x x x
Cough Cough 11% 7% x x x x x x
Vomiting Vomiting very common, 3% - 15% 1% - 9% x x x x x x x x x x x x x x x
Asthenia Fatigue common, 4% - 10% 1% - 6% x x x x x x x x x x x x x x x
Asthenia uncommon x x x x
Fatigue Fatigue common, 4% - 10% 1% - 6% x x x x x x x x x x x x x x x
Dysuria Strangury 2% - 8% 0% x x x x x x x
Dysuria 2% - 3% 0% x x x x x x x x
Strangury Strangury 2% - 8% 0% x x x x x x x
Somnolence Somnolence very common, 4% - 11% 3% - 5% x x x x x x x x x x x x x x x
Erectile dysfunction Erectile dysfunction 3% - 9% 0% - 1% x x x x x x x x x x x x x x x
Dizziness Dizziness 5% - 8% 2% - 4% x x x x x x x x x x x x x x x
Syncope very rare — uncommon x x x x x x x x x x x x x
Dysmenorrhoea Dysmenorrhoea 3% - 7% 2% - 3% x x x x x x x x x x x x x x x
Irritability Irritability common, 5% - 8% 3% - 5% x x x x x x x x x x x x x x x
Sinusitis Sinusitis 6% 4% x x x x x x
Vertigo Vertigo 6% 3% x x x x x x
Urinary hesitation Urinary hesitation postmarketing, 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Mydriasis Mydriasis common x
Pruritus Pruritus common x x x x x x x x x x
Urinary retention Urinary retention postmarketing, 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Depressive symptom Depressive symptom common x x x x x x x x
Dysphoria Dysphoria common x x x x x x x x
Ejaculation failure Ejaculation failure 5% 2% x x x x x x x
Initial insomnia Initial insomnia common x x x x
Terminal insomnia Terminal insomnia common x x x x x x x x x x x x x x x
Major depression Major depression common x x x x x x x x
Libido decreased Libido decreased 3% - 6% 1% - 2% x x x x x x x x x x x x x x x
Disturbance in sexual arousal Libido decreased 3% - 6% 1% - 2% x x x x x x x x x x x x x x x
Dermatitis Dermatitis 2% - 4% 1% - 2% x x x x x x x
Rash common, 2% 1% x x x x x x x x x
Dyspepsia Dyspepsia 4% - 8% 0% - 4% x x x x x x x x x x x x x x x
Hyperhidrosis Hyperhidrosis postmarketing, 4% 1% x x x x x x x x x
Sweating increased 4% 1% x x x x x x
Abnormal dreams Abnormal dreams 4% 3% x x x x x x x x
Ejaculation disorder Ejaculation disorder 3% - 5% 1% - 2% x x x x x x x x x x x x x x x
Nasopharyngitis Rhinorrhoea 4% 3% x x x x x x
Nasopharyngitis x x x x x x
Rhinorrhoea Rhinorrhoea 4% 3% x x x x x x
Diarrhoea Diarrhoea 3% - 4% 1% - 6% x x x x x x
Body temperature increased Body temperature increased postmarketing, 3% 2% x x x x x x x
Influenza Influenza 2% - 3% 1% x x x x x x x
Menstrual disorder Menstrual disorder 3% 2% x x x x x x
Palpitations Palpitations uncommon, 3% - 4% 1% x x x x x x x x x x x x x x x
Paraesthesia Paraesthesia postmarketing, 3% - 4% 0% - 2% x x x x x x x x x x x x x x
Prostatitis Prostatitis 3% 0% x x x x x x x x x x
Sinus headache Sinus headache 3% 1% x x x x x x x x x x x x
Chills Chills 3% 0% - 1% x x x x x x x x x
Rigors 3% 1% x x x x x x x
Myalgia Myalgia 3% 2% x x x x x x
Musculoskeletal discomfort Myalgia 3% 2% x x x x x x
Arthralgia x x x x x x
Ejaculation delayed Ejaculation delayed 3% - 4% 1% x x x x x x x x
Menopausal symptoms Hot flush 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Hot flush Hot flush 3% - 8% 0% - 1% x x x x x x x x x x x x x x x
Ear infection Ear infection 3% 1% x x x x x x
Sleep disorder Sleep disorder 3% - 4% 1% - 2% x x x x x x x x x x x x x x x
Constipation Constipation 0% - 10% 0% - 4% x x x x x x x x x x x x x x x
Rash Rash common, 2% 1% x x x x x x x x x
Flatulence Flatulence 2% 1% x x x x x x x x
Orgasm abnormal Orgasm abnormal 2% 1% x x x x x x x x x x
Thirst Thirst 2% 1% x x x
Tremor Tremor uncommon, 2% 0% x x x x x x x x x x x x x x x
Weight decreased Weight decreased common, 2% - 3% 0% - 1% x x x x x x x x x x x x x x x
Mood swings Mood swings 1% - 5% 0% - 2% x x x x x x x x x x x x x x x
Affect lability Mood swings 1% - 5% 0% - 2% x x x x x x x x x x x x x x x
Menstruation irregular Menstruation irregular 2% 0% x x x x x x x x x x x x x
Menstruation delayed Menstruation delayed 2% 1% x x x x x x
Nervousness Feeling jittery 2% 0% - 1% x x x x x x x x x
Nervousness x x x x x x x x
Feeling jittery Feeling jittery 2% 0% - 1% x x x x x x x x x
Therapeutic response unexpected Therapeutic response unexpected 2% - 3% 1% x x x x x x x x
Conjunctivitis Conjunctivitis uncommon x x x x x x x x x
Flushing Flushing uncommon x x x x x x x x x x
Sinus tachycardia Sinus tachycardia uncommon x x x x x x x x x x
Syncope Syncope vasovagal uncommon x
Syncope very rare — uncommon x x x x x x x x x x x x x
Presyncope Syncope vasovagal uncommon x
Aggression Aggression postmarketing x x x x x x x x x x x x x x x
Anxiety Anxiety postmarketing x x x x x x x x x
Mental disorder Mental disorder postmarketing x x x x x x
Coma Coma postmarketing x
Delirium Delirium postmarketing x
Depression Depression postmarketing x x x x x x x
Hallucination Hallucination postmarketing x x
Hostility Hostility postmarketing x
Hypoaesthesia Hypoaesthesia postmarketing x x x x x x x
Lethargy Lethargy postmarketing, 7% 4% x x x x x x x x x x x x x x
Muscle rigidity Muscle rigidity postmarketing x
Myoclonus Myoclonus postmarketing x
Nervous system disorder Nervous system disorder postmarketing x x x x x x x x x x x x x x x
Neuroleptic malignant syndrome Neuroleptic malignant syndrome postmarketing x
Pelvic pain Pelvic pain postmarketing x x x x x x x x
Psychotic disorder Psychotic disorder postmarketing x
Convulsion Convulsion postmarketing x x x x x x x x x x x
Suicide attempt Suicide attempt postmarketing x
Shock Syncope very rare — uncommon x x x x x x x x x x x x x
Loss of consciousness Syncope very rare — uncommon x x x x x x x x x x x x x
Angiopathy Angiopathy postmarketing x x x x x x x x x x x x x x x
Agitation Agitation postmarketing x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x x x x x x x
Autonomic nervous system imbalance Autonomic nervous system imbalance postmarketing x
Mania Mania postmarketing x
Depressed mood Depressed mood postmarketing, common x x x x x x x x
Suicidal ideation Suicidal ideation postmarketing x
Genital pain Genital pain male postmarketing x
Drug interaction Drug interaction postmarketing x
Completed suicide Completed suicide postmarketing x
Mental status changes Mental status changes postmarketing x
Erection increased Erection prolonged postmarketing x
Pre-existing disease Pre-existing disease very rare, postmarketing x x
Arthralgia Arthralgia x x x x x x
Back pain Back pain x x x x x x
Bone disorder Bone disorder x x x x x x
Breast disorder Breast disorder x x x x x x x x x x x x x x x
Chest pain Chest pain x x x x x x x x x x x x x x
Infection Infection x x x x x x x
Drug abuse Drug abuse x x
Dysgeusia Dysgeusia x
Excoriation Excoriation x x x x x x x x
Gastrointestinal disorder Gastrointestinal disorder x x x x x x x x x x x x x x x
Gastrointestinal symptom NOS x x
Cardiac disorder Cardiac disorder x x x x x x x x x x x x x x x
Mediastinal disorder Mediastinal disorder x x x x x x
Nasal congestion Nasal congestion x x x x x x
Tension Nervousness x x x x x x x x
Pain Pain x
Muscle spasms Muscle spasms x
Testicular pain Testicular pain x x x x
Upper respiratory tract infection Upper respiratory tract infection x x x x x x
Urethral disorder Urinary tract disorder x x x x x x x x x x x x x x x
Urinary tract disorder Urinary tract disorder x x x x x x x x x x x x x x x
Urticaria Urticaria x
Pollakiuria Micturition urgency x
Micturition urgency Micturition urgency x
Sinus congestion Sinus congestion x x x x x x
Viral diarrhoea Viral diarrhoea x x x x x x
Malnutrition Malnutrition x x x x x x x x x x x x x x x
Disorientation Disorientation x
Abnormal behaviour Abnormal behaviour x x
Oropharyngeal discomfort Throat sore x x x x x x
Oropharyngeal pain Throat sore x x x x x x
Peripheral coldness Peripheral coldness x x x x x x x x x x x x
Drug dependence Dependence psychological x x
Vision blurred Vision blurred x x x
Crying Tearfulness x x x x x x
Tearfulness Tearfulness x x x x x x
Dependence Dependence x x
Urine flow decreased Urine flow decreased x
Sexual dysfunction Sexual dysfunction x x x x x x x x x x x x x x
Infestation Infestation NOS x x
Laryngeal pain Pharyngolaryngeal pain x x x
Female sexual dysfunction Female sexual dysfunction x x x x x x x x x x x x x x
Hepatic failure Hepatic insufficiency x x
Feeling abnormal Feeling abnormal x x x x x x x x
Suicidal behaviour Suicidal behaviour x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Atomoxetine Hydrochloride / Strattera

Side effects:83
Source:FDA

ATOMOXETINE HYDROCHLORIDE / STRATTERA

Side effects:84
Source:FDA

atomoxetine HCl / Strattera

Side effects:84
Source:FDA

ATOMOXETINE HYDROCHLORIDE / STRATTERA

Side effects:84
Source:FDA

atomoxetine hydrochloride / Strattera

Side effects:89
Source:FDA

atomoxetine HCl / Strattera

Side effects:93
Source:FDA

ATOMOXETINE

Side effects:59
Source:FDA Structured Product Label

Atomoxetine

Side effects:65
Source:FDA Structured Product Label

ATOMOXETINE

Side effects:65
Source:FDA Structured Product Label

Atomoxetine

Side effects:68
Source:FDA Structured Product Label

Atomoxetine

Side effects:68
Source:FDA Structured Product Label

ATOMOXETINE

Side effects:82
Source:FDA Structured Product Label

ATOMOXETINE

Side effects:83
Source:FDA Structured Product Label

atomoxetine hydrochloride / Strattera

Side effects:88
Source:FDA

Atomoxetine capsules / Strattera, Capsule

Side effects:96
Source:Medsafe

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label